Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Surgical Procedures | 25 | 2019 | 1476 | 3.590 |
Why?
|
Lower Extremity | 15 | 2018 | 1158 | 3.060 |
Why?
|
Ischemia | 20 | 2021 | 1907 | 2.850 |
Why?
|
Peripheral Arterial Disease | 14 | 2018 | 1188 | 2.490 |
Why?
|
Thoracic Outlet Syndrome | 3 | 2021 | 85 | 1.520 |
Why?
|
Endarterectomy, Carotid | 12 | 2022 | 546 | 1.450 |
Why?
|
Economic Competition | 4 | 2016 | 214 | 1.300 |
Why?
|
Carotid Stenosis | 11 | 2022 | 854 | 1.300 |
Why?
|
Limb Salvage | 10 | 2018 | 433 | 1.230 |
Why?
|
Intermittent Claudication | 6 | 2016 | 309 | 1.180 |
Why?
|
Aortic Aneurysm, Abdominal | 9 | 2022 | 1187 | 1.180 |
Why?
|
Peripheral Vascular Diseases | 6 | 2013 | 549 | 1.140 |
Why?
|
Amputees | 2 | 2015 | 75 | 0.950 |
Why?
|
Military Medicine | 4 | 2018 | 176 | 0.910 |
Why?
|
Stents | 12 | 2022 | 3280 | 0.850 |
Why?
|
Quality Indicators, Health Care | 6 | 2019 | 1831 | 0.800 |
Why?
|
Veins | 5 | 2016 | 770 | 0.780 |
Why?
|
Surgical Procedures, Operative | 7 | 2019 | 1877 | 0.780 |
Why?
|
Vascular Patency | 10 | 2016 | 887 | 0.750 |
Why?
|
Chi-Square Distribution | 13 | 2017 | 3503 | 0.730 |
Why?
|
Commerce | 2 | 2016 | 592 | 0.720 |
Why?
|
Healthcare Disparities | 6 | 2018 | 3155 | 0.720 |
Why?
|
Leg | 5 | 2013 | 1116 | 0.700 |
Why?
|
Multivariate Analysis | 19 | 2017 | 12243 | 0.690 |
Why?
|
Angioplasty | 4 | 2015 | 364 | 0.690 |
Why?
|
Angioplasty, Balloon | 5 | 2016 | 653 | 0.680 |
Why?
|
Blood Vessel Prosthesis Implantation | 8 | 2022 | 1391 | 0.670 |
Why?
|
Hematoma | 4 | 2017 | 758 | 0.660 |
Why?
|
Postoperative Complications | 17 | 2022 | 15281 | 0.630 |
Why?
|
Vascular Grafting | 2 | 2018 | 143 | 0.610 |
Why?
|
Seroma | 1 | 2017 | 71 | 0.580 |
Why?
|
Competitive Medical Plans | 1 | 2016 | 24 | 0.560 |
Why?
|
Quality of Life | 9 | 2016 | 12788 | 0.540 |
Why?
|
Length of Stay | 10 | 2019 | 6311 | 0.540 |
Why?
|
Surgical Wound Infection | 4 | 2017 | 1539 | 0.530 |
Why?
|
Patient Discharge | 6 | 2019 | 3317 | 0.530 |
Why?
|
Health Resources | 3 | 2013 | 912 | 0.510 |
Why?
|
Silver Compounds | 1 | 2014 | 22 | 0.500 |
Why?
|
Salaries and Fringe Benefits | 1 | 2017 | 263 | 0.500 |
Why?
|
Treatment Outcome | 47 | 2022 | 63042 | 0.500 |
Why?
|
General Surgery | 5 | 2022 | 1636 | 0.490 |
Why?
|
Risk Assessment | 28 | 2022 | 23327 | 0.480 |
Why?
|
Health Care Sector | 1 | 2016 | 194 | 0.470 |
Why?
|
Odds Ratio | 11 | 2017 | 9848 | 0.460 |
Why?
|
Time Factors | 30 | 2022 | 40038 | 0.460 |
Why?
|
Phlebography | 1 | 2014 | 333 | 0.460 |
Why?
|
Patient Readmission | 8 | 2019 | 3117 | 0.450 |
Why?
|
Specialties, Surgical | 2 | 2018 | 391 | 0.450 |
Why?
|
Ribs | 1 | 2014 | 252 | 0.440 |
Why?
|
Alginates | 1 | 2014 | 252 | 0.440 |
Why?
|
Logistic Models | 14 | 2022 | 13404 | 0.440 |
Why?
|
Polyesters | 1 | 2014 | 362 | 0.430 |
Why?
|
Bandages | 1 | 2014 | 266 | 0.430 |
Why?
|
Kidney Transplantation | 4 | 2016 | 4251 | 0.430 |
Why?
|
Endovascular Procedures | 6 | 2022 | 1980 | 0.430 |
Why?
|
Decision Support Techniques | 3 | 2017 | 1956 | 0.420 |
Why?
|
Facial Transplantation | 1 | 2015 | 226 | 0.410 |
Why?
|
Anti-Infective Agents, Local | 1 | 2014 | 250 | 0.410 |
Why?
|
Health Services Needs and Demand | 2 | 2017 | 1411 | 0.410 |
Why?
|
Polyethylenes | 1 | 2014 | 285 | 0.410 |
Why?
|
Fee-for-Service Plans | 1 | 2017 | 694 | 0.410 |
Why?
|
United States | 39 | 2022 | 69859 | 0.410 |
Why?
|
Analgesics, Opioid | 2 | 2018 | 3677 | 0.400 |
Why?
|
Patient Selection | 10 | 2020 | 4210 | 0.400 |
Why?
|
Aortic Rupture | 2 | 2014 | 312 | 0.400 |
Why?
|
Proportional Hazards Models | 16 | 2016 | 12354 | 0.400 |
Why?
|
Reimbursement Mechanisms | 1 | 2017 | 670 | 0.390 |
Why?
|
Pain, Postoperative | 2 | 2019 | 1642 | 0.390 |
Why?
|
Aged | 52 | 2022 | 163178 | 0.380 |
Why?
|
Health Services Accessibility | 4 | 2022 | 5136 | 0.380 |
Why?
|
Hospital Costs | 2 | 2017 | 985 | 0.380 |
Why?
|
Male | 71 | 2022 | 349776 | 0.360 |
Why?
|
Physician's Role | 1 | 2017 | 942 | 0.360 |
Why?
|
Health Care Costs | 4 | 2017 | 3207 | 0.350 |
Why?
|
Exercise Test | 2 | 2015 | 2074 | 0.350 |
Why?
|
Comorbidity | 12 | 2016 | 10380 | 0.340 |
Why?
|
Female | 72 | 2022 | 380020 | 0.340 |
Why?
|
Benchmarking | 2 | 2016 | 1042 | 0.340 |
Why?
|
Databases as Topic | 2 | 2011 | 474 | 0.340 |
Why?
|
Specialization | 1 | 2014 | 775 | 0.340 |
Why?
|
Middle Aged | 50 | 2022 | 213241 | 0.340 |
Why?
|
Wound Healing | 3 | 2017 | 2776 | 0.340 |
Why?
|
Quality Improvement | 6 | 2019 | 3750 | 0.330 |
Why?
|
Social Behavior | 1 | 2015 | 1126 | 0.330 |
Why?
|
Magnetic Resonance Angiography | 2 | 2014 | 1444 | 0.330 |
Why?
|
Hospitals | 3 | 2017 | 3953 | 0.330 |
Why?
|
Face | 1 | 2015 | 993 | 0.330 |
Why?
|
Humans | 101 | 2022 | 743811 | 0.320 |
Why?
|
Data Mining | 1 | 2013 | 537 | 0.320 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1636 | 0.320 |
Why?
|
Ultrasonography, Doppler, Duplex | 4 | 2016 | 205 | 0.310 |
Why?
|
Risk Factors | 31 | 2022 | 72252 | 0.310 |
Why?
|
Health Expenditures | 2 | 2017 | 2348 | 0.310 |
Why?
|
Retrospective Studies | 41 | 2022 | 77410 | 0.310 |
Why?
|
Reoperation | 8 | 2019 | 4200 | 0.300 |
Why?
|
Patient-Centered Care | 2 | 2015 | 1438 | 0.300 |
Why?
|
Women | 1 | 2009 | 230 | 0.300 |
Why?
|
Military Personnel | 5 | 2020 | 1133 | 0.290 |
Why?
|
Kaplan-Meier Estimate | 12 | 2016 | 6539 | 0.290 |
Why?
|
Popliteal Artery | 3 | 2016 | 317 | 0.290 |
Why?
|
Aged, 80 and over | 25 | 2019 | 57744 | 0.290 |
Why?
|
Quality Assurance, Health Care | 2 | 2015 | 2211 | 0.290 |
Why?
|
Extremities | 2 | 2014 | 867 | 0.290 |
Why?
|
Azygos Vein | 1 | 2006 | 21 | 0.290 |
Why?
|
Carotid Artery Diseases | 4 | 2015 | 875 | 0.290 |
Why?
|
Graft Occlusion, Vascular | 3 | 2013 | 549 | 0.280 |
Why?
|
Tissue and Organ Procurement | 1 | 2014 | 896 | 0.280 |
Why?
|
Critical Illness | 8 | 2016 | 2670 | 0.280 |
Why?
|
Disability Evaluation | 1 | 2013 | 1828 | 0.270 |
Why?
|
Linear Models | 5 | 2017 | 5952 | 0.270 |
Why?
|
Social Support | 1 | 2015 | 2118 | 0.270 |
Why?
|
Office Visits | 2 | 2022 | 598 | 0.260 |
Why?
|
Postoperative Hemorrhage | 2 | 2012 | 409 | 0.260 |
Why?
|
Iliac Vein | 1 | 2004 | 72 | 0.240 |
Why?
|
Graft Survival | 6 | 2016 | 3734 | 0.240 |
Why?
|
Socioeconomic Factors | 4 | 2022 | 7784 | 0.240 |
Why?
|
Liver Transplantation | 1 | 2015 | 2119 | 0.240 |
Why?
|
Wounds, Nonpenetrating | 2 | 2010 | 795 | 0.240 |
Why?
|
Insurance Benefits | 2 | 2016 | 183 | 0.230 |
Why?
|
Databases, Factual | 4 | 2019 | 7729 | 0.230 |
Why?
|
Multiple Trauma | 1 | 2006 | 367 | 0.230 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2534 | 0.220 |
Why?
|
Pain | 1 | 2018 | 4987 | 0.220 |
Why?
|
Hospital Mortality | 3 | 2015 | 5316 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2017 | 9944 | 0.210 |
Why?
|
Survivors | 1 | 2013 | 2291 | 0.210 |
Why?
|
Arterial Occlusive Diseases | 3 | 2019 | 793 | 0.210 |
Why?
|
Registries | 11 | 2022 | 8090 | 0.210 |
Why?
|
Diagnostic Imaging | 2 | 2014 | 3503 | 0.210 |
Why?
|
Sex Factors | 6 | 2018 | 10394 | 0.200 |
Why?
|
Emergencies | 2 | 2019 | 1170 | 0.200 |
Why?
|
Tissue Donors | 3 | 2016 | 2241 | 0.200 |
Why?
|
Vascular Diseases | 1 | 2010 | 1161 | 0.200 |
Why?
|
Macrolides | 1 | 2022 | 201 | 0.200 |
Why?
|
Health Facility Environment | 1 | 2021 | 34 | 0.200 |
Why?
|
Hospital Bed Capacity | 2 | 2014 | 215 | 0.200 |
Why?
|
Residence Characteristics | 3 | 2017 | 2050 | 0.190 |
Why?
|
Aorta, Thoracic | 2 | 2006 | 1084 | 0.190 |
Why?
|
Boston | 7 | 2016 | 9310 | 0.190 |
Why?
|
California | 2 | 2015 | 1402 | 0.190 |
Why?
|
Femoral Artery | 3 | 2016 | 845 | 0.190 |
Why?
|
Adult | 23 | 2022 | 213889 | 0.180 |
Why?
|
Subclavian Artery | 1 | 2021 | 130 | 0.180 |
Why?
|
Stroke | 7 | 2022 | 9975 | 0.180 |
Why?
|
Insurance | 1 | 2021 | 111 | 0.180 |
Why?
|
Diffusion of Innovation | 2 | 2017 | 725 | 0.180 |
Why?
|
Insurance Carriers | 1 | 2021 | 157 | 0.170 |
Why?
|
Body Mass Index | 1 | 2017 | 12718 | 0.170 |
Why?
|
Iliac Artery | 2 | 2019 | 364 | 0.170 |
Why?
|
Recovery of Function | 4 | 2015 | 2922 | 0.170 |
Why?
|
Veterans Health | 2 | 2018 | 216 | 0.160 |
Why?
|
After-Hours Care | 1 | 2019 | 102 | 0.160 |
Why?
|
Imaging, Three-Dimensional | 1 | 2012 | 4033 | 0.160 |
Why?
|
Cohort Studies | 11 | 2018 | 40545 | 0.160 |
Why?
|
Health Services Research | 3 | 2013 | 1836 | 0.160 |
Why?
|
Health Benefit Plans, Employee | 2 | 2019 | 332 | 0.160 |
Why?
|
Medicare | 6 | 2022 | 6565 | 0.150 |
Why?
|
Aneurysm | 1 | 2021 | 339 | 0.150 |
Why?
|
Ambulatory Care | 2 | 2019 | 2707 | 0.150 |
Why?
|
Renal Insufficiency | 2 | 2014 | 805 | 0.150 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2019 | 392 | 0.150 |
Why?
|
Incidence | 8 | 2016 | 20948 | 0.150 |
Why?
|
Comparative Effectiveness Research | 3 | 2022 | 680 | 0.140 |
Why?
|
Trust | 1 | 2021 | 505 | 0.140 |
Why?
|
Analgesia, Epidural | 1 | 2019 | 326 | 0.140 |
Why?
|
Research Design | 5 | 2021 | 5983 | 0.140 |
Why?
|
Propensity Score | 4 | 2022 | 1781 | 0.140 |
Why?
|
Treatment Failure | 2 | 2015 | 2617 | 0.140 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2022 | 770 | 0.140 |
Why?
|
Follow-Up Studies | 12 | 2015 | 39001 | 0.140 |
Why?
|
Saphenous Vein | 2 | 2012 | 532 | 0.140 |
Why?
|
National Health Insurance, United States | 1 | 2016 | 104 | 0.130 |
Why?
|
Societies, Medical | 3 | 2018 | 3740 | 0.130 |
Why?
|
Climate Change | 1 | 2021 | 418 | 0.130 |
Why?
|
Surgical Wound Dehiscence | 1 | 2017 | 214 | 0.130 |
Why?
|
Waist-Hip Ratio | 1 | 2017 | 516 | 0.130 |
Why?
|
Intraoperative Care | 1 | 2019 | 767 | 0.130 |
Why?
|
Reproducibility of Results | 5 | 2015 | 19894 | 0.130 |
Why?
|
Renal Dialysis | 2 | 2019 | 1783 | 0.130 |
Why?
|
Subclavian Vein | 1 | 2014 | 54 | 0.130 |
Why?
|
Oligonucleotides | 2 | 2008 | 572 | 0.130 |
Why?
|
Risk Adjustment | 2 | 2016 | 594 | 0.120 |
Why?
|
Hexuronic Acids | 1 | 2014 | 144 | 0.120 |
Why?
|
Glucuronic Acid | 1 | 2014 | 148 | 0.120 |
Why?
|
Walking | 2 | 2015 | 1182 | 0.120 |
Why?
|
Operating Rooms | 1 | 2021 | 817 | 0.120 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2001 | 1503 | 0.120 |
Why?
|
Subclavian Steal Syndrome | 1 | 2014 | 23 | 0.120 |
Why?
|
Obstetrics | 1 | 2021 | 657 | 0.120 |
Why?
|
Axillary Artery | 1 | 2014 | 50 | 0.120 |
Why?
|
Carotid Arteries | 2 | 2015 | 949 | 0.120 |
Why?
|
Diabetes Mellitus | 3 | 2013 | 5752 | 0.120 |
Why?
|
Cause of Death | 1 | 2004 | 3580 | 0.120 |
Why?
|
Texas | 1 | 2014 | 390 | 0.110 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 432 | 0.110 |
Why?
|
Cost of Illness | 2 | 2017 | 1859 | 0.110 |
Why?
|
Intention to Treat Analysis | 1 | 2014 | 426 | 0.110 |
Why?
|
Models, Economic | 1 | 2017 | 712 | 0.110 |
Why?
|
Postoperative Period | 1 | 2018 | 1841 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 964 | 0.110 |
Why?
|
Subcutaneous Fat | 2 | 2013 | 391 | 0.110 |
Why?
|
Preoperative Period | 1 | 2015 | 550 | 0.110 |
Why?
|
Geographic Information Systems | 1 | 2015 | 281 | 0.110 |
Why?
|
Hospitals, Military | 3 | 2017 | 67 | 0.110 |
Why?
|
Administration, Topical | 1 | 2014 | 689 | 0.110 |
Why?
|
Health Care Rationing | 1 | 2016 | 437 | 0.110 |
Why?
|
Anticoagulants | 1 | 2007 | 4599 | 0.110 |
Why?
|
Point-of-Care Systems | 1 | 2021 | 1177 | 0.110 |
Why?
|
Angiography | 2 | 2016 | 1638 | 0.110 |
Why?
|
Radiography, Interventional | 1 | 2019 | 1095 | 0.100 |
Why?
|
Double-Blind Method | 3 | 2016 | 12020 | 0.100 |
Why?
|
Health Services | 1 | 2017 | 758 | 0.100 |
Why?
|
Inflammation | 2 | 2013 | 10629 | 0.100 |
Why?
|
Insurance, Health | 2 | 2017 | 2492 | 0.100 |
Why?
|
Multicenter Studies as Topic | 1 | 2017 | 1676 | 0.100 |
Why?
|
Preoperative Care | 3 | 2020 | 2251 | 0.100 |
Why?
|
Data Interpretation, Statistical | 2 | 2013 | 2715 | 0.100 |
Why?
|
Meglumine | 1 | 2012 | 149 | 0.100 |
Why?
|
Polyethylene Terephthalates | 1 | 2012 | 116 | 0.100 |
Why?
|
Mobility Limitation | 1 | 2015 | 409 | 0.100 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 941 | 0.100 |
Why?
|
Adrenalectomy | 1 | 2013 | 342 | 0.100 |
Why?
|
Tanzania | 1 | 2015 | 1346 | 0.100 |
Why?
|
Hospitalization | 2 | 2010 | 10259 | 0.100 |
Why?
|
Ultrasonography, Interventional | 2 | 2010 | 1486 | 0.090 |
Why?
|
Young Adult | 9 | 2022 | 56392 | 0.090 |
Why?
|
Prostatectomy | 2 | 2017 | 1879 | 0.090 |
Why?
|
Caloric Restriction | 1 | 2012 | 302 | 0.090 |
Why?
|
Models, Statistical | 2 | 2015 | 5100 | 0.090 |
Why?
|
Age Factors | 6 | 2017 | 18355 | 0.090 |
Why?
|
Predictive Value of Tests | 4 | 2014 | 15067 | 0.090 |
Why?
|
Monte Carlo Method | 1 | 2015 | 1254 | 0.090 |
Why?
|
Needs Assessment | 1 | 2016 | 1146 | 0.090 |
Why?
|
Decompression, Surgical | 1 | 2014 | 594 | 0.090 |
Why?
|
Drug Costs | 1 | 2017 | 1105 | 0.090 |
Why?
|
Netherlands | 1 | 2014 | 2170 | 0.090 |
Why?
|
Communication | 2 | 2021 | 3748 | 0.090 |
Why?
|
Database Management Systems | 1 | 2010 | 270 | 0.080 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1680 | 0.080 |
Why?
|
Aortography | 1 | 2010 | 437 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2014 | 1180 | 0.080 |
Why?
|
Brachytherapy | 1 | 2016 | 1247 | 0.080 |
Why?
|
Gadolinium DTPA | 1 | 2012 | 836 | 0.080 |
Why?
|
Hospital Charges | 1 | 2010 | 362 | 0.080 |
Why?
|
Patient Care Planning | 1 | 2014 | 915 | 0.080 |
Why?
|
Transplantation, Autologous | 3 | 2009 | 2123 | 0.080 |
Why?
|
Endothelium, Vascular | 1 | 2001 | 4459 | 0.080 |
Why?
|
Organometallic Compounds | 1 | 2012 | 665 | 0.080 |
Why?
|
Patient Care Team | 1 | 2019 | 2528 | 0.080 |
Why?
|
Morbidity | 1 | 2013 | 1768 | 0.080 |
Why?
|
Electronic Health Records | 2 | 2021 | 4467 | 0.080 |
Why?
|
Survival Analysis | 4 | 2015 | 10251 | 0.080 |
Why?
|
ROC Curve | 2 | 2013 | 3527 | 0.080 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2013 | 740 | 0.080 |
Why?
|
Nutritional Status | 1 | 2016 | 1608 | 0.070 |
Why?
|
Pericardium | 1 | 2012 | 667 | 0.070 |
Why?
|
Vascular System Injuries | 1 | 2010 | 250 | 0.070 |
Why?
|
Adiposity | 1 | 2017 | 1806 | 0.070 |
Why?
|
Blood Vessels | 1 | 2013 | 1124 | 0.070 |
Why?
|
Prospective Studies | 6 | 2016 | 53250 | 0.070 |
Why?
|
Delayed Graft Function | 1 | 2006 | 48 | 0.070 |
Why?
|
Emergency Medicine | 1 | 2016 | 1205 | 0.070 |
Why?
|
Photoplethysmography | 1 | 2006 | 56 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3530 | 0.070 |
Why?
|
Severity of Illness Index | 6 | 2019 | 15526 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2014 | 2453 | 0.070 |
Why?
|
Pilot Projects | 2 | 2021 | 8316 | 0.070 |
Why?
|
Social Class | 1 | 2015 | 1997 | 0.070 |
Why?
|
Inguinal Canal | 1 | 2005 | 69 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 3 | 2014 | 20121 | 0.070 |
Why?
|
Decision Support Systems, Clinical | 1 | 2014 | 1164 | 0.060 |
Why?
|
Neuroblastoma | 1 | 2013 | 1226 | 0.060 |
Why?
|
Regression Analysis | 1 | 2015 | 6457 | 0.060 |
Why?
|
Patient Participation | 1 | 2014 | 1457 | 0.060 |
Why?
|
Memory | 1 | 2014 | 2173 | 0.060 |
Why?
|
Anesthesiology | 1 | 2015 | 1060 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 2874 | 0.060 |
Why?
|
Aortic Aneurysm | 1 | 2009 | 644 | 0.060 |
Why?
|
Adolescent | 5 | 2022 | 85729 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3089 | 0.060 |
Why?
|
Radiography | 2 | 2006 | 7010 | 0.060 |
Why?
|
North America | 1 | 2007 | 1249 | 0.060 |
Why?
|
Activities of Daily Living | 1 | 2013 | 2419 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1888 | 0.060 |
Why?
|
Viscera | 1 | 2004 | 139 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 14714 | 0.060 |
Why?
|
Blood Vessel Prosthesis | 2 | 2019 | 933 | 0.060 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 452 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2019 | 4370 | 0.060 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2006 | 277 | 0.060 |
Why?
|
Sex Distribution | 1 | 2008 | 2298 | 0.060 |
Why?
|
Minority Groups | 1 | 2010 | 1222 | 0.060 |
Why?
|
Aorta | 1 | 2010 | 2062 | 0.050 |
Why?
|
Probability | 2 | 2005 | 2505 | 0.050 |
Why?
|
Resistin | 2 | 2013 | 170 | 0.050 |
Why?
|
Retreatment | 2 | 2016 | 609 | 0.050 |
Why?
|
Computer Literacy | 1 | 2022 | 43 | 0.050 |
Why?
|
Plasminogen Activator Inhibitor 1 | 2 | 2013 | 281 | 0.050 |
Why?
|
Blood Transfusion | 2 | 2019 | 1301 | 0.050 |
Why?
|
Prevalence | 2 | 2010 | 15211 | 0.050 |
Why?
|
Health Status Indicators | 1 | 2007 | 970 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8385 | 0.050 |
Why?
|
Hand | 1 | 2006 | 884 | 0.050 |
Why?
|
Cardiovascular Agents | 1 | 2007 | 850 | 0.050 |
Why?
|
Laparoscopy | 1 | 2013 | 2148 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2789 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3280 | 0.050 |
Why?
|
Constriction, Pathologic | 2 | 2016 | 1108 | 0.050 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 1516 | 0.040 |
Why?
|
Administration, Oral | 1 | 2007 | 3912 | 0.040 |
Why?
|
Penicillins | 1 | 2022 | 380 | 0.040 |
Why?
|
Computer Simulation | 1 | 2013 | 6188 | 0.040 |
Why?
|
United States Department of Defense | 1 | 2019 | 32 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4687 | 0.040 |
Why?
|
Disease Progression | 1 | 2016 | 13273 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 3320 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2006 | 1524 | 0.040 |
Why?
|
Graft Rejection | 3 | 2012 | 4398 | 0.040 |
Why?
|
Recurrence | 4 | 2016 | 8337 | 0.040 |
Why?
|
Insurance Coverage | 2 | 2022 | 1900 | 0.040 |
Why?
|
Contrast Media | 1 | 2012 | 5301 | 0.040 |
Why?
|
Information Systems | 1 | 2021 | 410 | 0.040 |
Why?
|
Permeability | 1 | 2001 | 738 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 6773 | 0.040 |
Why?
|
Telephone | 1 | 2022 | 617 | 0.040 |
Why?
|
Growth Substances | 1 | 2001 | 784 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2008 | 1859 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3608 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7324 | 0.040 |
Why?
|
Ultrasonography, Mammary | 1 | 2020 | 250 | 0.040 |
Why?
|
Occult Blood | 1 | 2018 | 176 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2015 | 25032 | 0.040 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2004 | 691 | 0.040 |
Why?
|
Health Status Disparities | 1 | 2009 | 1796 | 0.040 |
Why?
|
Endoleak | 1 | 2018 | 106 | 0.040 |
Why?
|
Medicaid | 1 | 2010 | 2736 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4569 | 0.040 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2022 | 455 | 0.040 |
Why?
|
Smoking | 1 | 2014 | 8984 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12954 | 0.040 |
Why?
|
Government Agencies | 1 | 2017 | 156 | 0.040 |
Why?
|
Health Status | 1 | 2010 | 4031 | 0.040 |
Why?
|
Focus Groups | 1 | 2021 | 1320 | 0.030 |
Why?
|
Internship and Residency | 1 | 2015 | 5787 | 0.030 |
Why?
|
Leptin | 2 | 2013 | 1600 | 0.030 |
Why?
|
Massachusetts | 2 | 2022 | 8660 | 0.030 |
Why?
|
Outpatients | 1 | 2022 | 1488 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2007 | 5388 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2018 | 719 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1582 | 0.030 |
Why?
|
Erectile Dysfunction | 1 | 2017 | 436 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2022 | 21733 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2018 | 491 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2001 | 1351 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 950 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2021 | 1385 | 0.030 |
Why?
|
Insulin Resistance | 1 | 2007 | 3863 | 0.030 |
Why?
|
Professional Practice | 1 | 2015 | 326 | 0.030 |
Why?
|
Physician Assistants | 1 | 2015 | 192 | 0.030 |
Why?
|
Cell Division | 1 | 2001 | 4568 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 35409 | 0.030 |
Why?
|
Urinary Incontinence | 1 | 2017 | 496 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 2018 | 638 | 0.030 |
Why?
|
Cerebral Revascularization | 1 | 2015 | 238 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 20827 | 0.030 |
Why?
|
Qualitative Research | 1 | 2021 | 2682 | 0.030 |
Why?
|
Efficiency | 1 | 2015 | 462 | 0.030 |
Why?
|
Heart Failure | 2 | 2014 | 10896 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1503 | 0.030 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2018 | 868 | 0.030 |
Why?
|
Coronary Artery Bypass | 2 | 2014 | 2288 | 0.030 |
Why?
|
Hospitals, General | 1 | 2016 | 749 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2015 | 397 | 0.020 |
Why?
|
Blood Pressure | 1 | 2006 | 8551 | 0.020 |
Why?
|
Polypharmacy | 1 | 2013 | 294 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 2016 | 934 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2001 | 2638 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2013 | 620 | 0.020 |
Why?
|
Perioperative Care | 1 | 2018 | 1002 | 0.020 |
Why?
|
Prognosis | 2 | 2010 | 29052 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2013 | 690 | 0.020 |
Why?
|
Aneurysm, False | 1 | 2012 | 276 | 0.020 |
Why?
|
Mammography | 1 | 2020 | 2475 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2603 | 0.020 |
Why?
|
Survival Rate | 2 | 2014 | 12786 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2012 | 987 | 0.020 |
Why?
|
Interleukins | 1 | 2013 | 791 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2016 | 1928 | 0.020 |
Why?
|
Appendectomy | 1 | 2010 | 401 | 0.020 |
Why?
|
Fees and Charges | 1 | 2008 | 195 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1917 | 0.020 |
Why?
|
Life Tables | 1 | 2007 | 363 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3391 | 0.020 |
Why?
|
Adiponectin | 1 | 2013 | 1101 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6356 | 0.020 |
Why?
|
Cholecystectomy | 1 | 2008 | 395 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2007 | 520 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2883 | 0.020 |
Why?
|
Child, Preschool | 2 | 2022 | 40964 | 0.020 |
Why?
|
Cattle | 1 | 2012 | 3917 | 0.020 |
Why?
|
Trauma Centers | 1 | 2010 | 891 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2010 | 576 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2007 | 458 | 0.020 |
Why?
|
Attention | 1 | 2015 | 2393 | 0.020 |
Why?
|
Brachial Artery | 1 | 2006 | 369 | 0.020 |
Why?
|
Observer Variation | 1 | 2010 | 2592 | 0.020 |
Why?
|
Models, Biological | 1 | 2001 | 9582 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7172 | 0.010 |
Why?
|
Mesenteric Artery, Superior | 1 | 2004 | 101 | 0.010 |
Why?
|
Forecasting | 1 | 2013 | 2950 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2401 | 0.010 |
Why?
|
Fingers | 1 | 2006 | 513 | 0.010 |
Why?
|
Equipment Design | 1 | 2012 | 3574 | 0.010 |
Why?
|
Colectomy | 1 | 2008 | 680 | 0.010 |
Why?
|
Anesthesia | 1 | 2015 | 1562 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2001 | 11478 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2013 | 5078 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2013 | 3208 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6895 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4848 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5251 | 0.010 |
Why?
|
Renal Artery | 1 | 2004 | 399 | 0.010 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2013 | 1458 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4422 | 0.010 |
Why?
|
Bariatric Surgery | 1 | 2010 | 952 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7908 | 0.010 |
Why?
|
Animals | 3 | 2012 | 168660 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9139 | 0.010 |
Why?
|
Phenotype | 1 | 2013 | 16361 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 29140 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 9239 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2016 | 11708 | 0.010 |
Why?
|
Child | 1 | 2022 | 77637 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11059 | 0.010 |
Why?
|
Infant | 1 | 2013 | 35122 | 0.010 |
Why?
|
Kidney | 1 | 2006 | 7185 | 0.010 |
Why?
|
Obesity | 1 | 2013 | 12744 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15142 | 0.000 |
Why?
|